Jokalvemiel (Clotrimazole)

Clotrimazole blocks the fungal enzyme lanosterol 14α‑demethylase, which is essential for synthesising ergosterol, a key component of fungal cell membranes. Inhibiting this pathway disrupts membrane integrity, leading to increased permeability and fungal cell death, thereby clearing the infection.

The dosage of Jokalvemiel is determined by the prescribing healthcare professional based on the infection type, severity, patient age and body surface area. Typically, a thin layer is applied to the affected area once or twice daily, but exact instructions should follow the prescriber’s order.

Safety data for topical clotrimazole in pregnancy and lactation are limited. Generally, it is considered low risk because systemic absorption is minimal, but pregnant or nursing women should consult their healthcare provider before using Jokalvemiel to weigh potential benefits and risks.

To place an order, submit an enquiry on the Jokalvemiel product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Jokalvemiel contains clotrimazole, an imidazole class antifungal, which offers broad activity against dermatophytes and yeasts. Compared with allylamine agents such as terbinafine, clotrimazole is generally less irritating but may require longer treatment duration. Choice of therapy depends on infection type, patient tolerance and clinician preference.

Store Jokalvemiel at room temperature, below 25 °C (77 °F). Keep the product in its original packaging, protect it from excess moisture, heat and direct sunlight. Do not freeze the cream, and ensure the container is tightly closed when not in use.

Clean and dry the affected skin area before use. Apply a thin, even layer of Jokalvemiel to the lesion and a small margin of surrounding skin, usually once or twice daily as directed by a healthcare professional. Wash hands after application and avoid covering the area with airtight dressings unless advised.

While rare, serious adverse reactions can include severe allergic responses such as contact dermatitis, swelling of the face or lips, difficulty breathing, and rare systemic hypersensitivity like Stevens‑Johnson syndrome. If any of these occur, discontinue use immediately and seek urgent medical attention.

Jokalvemiel should not be used by individuals with known hypersensitivity to clotrimazole or any other component of the formulation. It is also contraindicated on severely damaged, inflamed or infected skin where the barrier is compromised, and should be avoided in infants under two years without medical advice.